Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
04/24/2013 | CN101553219B Urea and sulfamide derivatives as TAFIa inhibitors |
04/24/2013 | CN101530450B Method for preparing pterocarpus indicus ethanol extract used for endothelium-dependent vasodilation agent and applications of method |
04/24/2013 | CN101522644B Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
04/24/2013 | CN101501049B Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
04/24/2013 | CN101272769B Benzoquinones of enhanced bioavailability |
04/24/2013 | CN101265226B Compounds and methods for delivery of prostacyclin analogs |
04/23/2013 | US8426588 Phenylalanine derivatives |
04/23/2013 | US8426431 Substituted 2-aminoacetamides and the use thereof |
04/23/2013 | US8426376 Angiogenesis inhibitor |
04/23/2013 | US8426365 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
04/23/2013 | US8426358 Methods for treating atherosclerosis |
04/23/2013 | CA2634168C Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
04/23/2013 | CA2557989C Sulfated oligosaccharide derivatives |
04/23/2013 | CA2555712C Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein |
04/23/2013 | CA2549954C Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
04/23/2013 | CA2410563C Methods for preventing strokes by inducing tolerance to e-selectin |
04/23/2013 | CA2381125C Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
04/18/2013 | WO2013055929A1 Non-n-glycosylated recombinant human annexin a2 |
04/18/2013 | WO2013055385A2 Methods of treating age related disorders |
04/18/2013 | WO2013054830A1 Monoclonal antibody against el, inhibiting el enzymatic activity |
04/18/2013 | WO2013054351A1 Heterocyclic compounds |
04/18/2013 | WO2013054267A1 Synergistic composition for preventing and treating disorders connected with ageing |
04/18/2013 | WO2013054153A1 Nutlin compounds for use in he treatment of pulmonary hypertension |
04/18/2013 | WO2013053937A1 A deproteinised calf blood preparation for use in prevention or treatment of post-stroke cognitive impairment |
04/18/2013 | WO2013053287A1 Derivative of butylphthalide and preparation method and use thereof |
04/18/2013 | WO2013053201A1 Compositions and methods for treating heart failure |
04/18/2013 | WO2013053158A1 Compositions and methods for treating heart failure |
04/18/2013 | WO2013053076A1 Compositions and methods for treating heart failure |
04/18/2013 | WO2013053021A1 ANTIBODIES TO CD1d |
04/18/2013 | WO2013020184A9 Flavonoid compounds, and methods of use thereof |
04/18/2013 | WO2012054718A8 Treating long qt syndrome |
04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
04/18/2013 | US20130095569 Pregnancy-associated plasma protein-a2 (papp-a2) polynucleotides |
04/18/2013 | US20130095549 Tweak receptor |
04/18/2013 | US20130095482 Methods of detecting pregnancy-associated plasma protein-a2 (papp-a2) |
04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
04/18/2013 | US20130095065 Methods for Treating Vascular Leak Syndrome and Cancer |
04/18/2013 | US20130095060 Pharmaceutical composition for promoting arteriogenesis, and preparation method and applications for the same |
04/18/2013 | DE112011102356T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit dem Herz-Kreislauf-System in Verbindung stehen A pharmaceutical combination compositions and methods for treating diseases or conditions associated with the cardiovascular system |
04/18/2013 | CA2851741A1 Derivative of butylphthalide and preparation method and use thereof |
04/18/2013 | CA2850961A1 Antibodies to cd1d |
04/18/2013 | CA2850830A1 Methods for treating vascular leak syndrome and cancer |
04/18/2013 | CA2850824A1 Treatment of ocular disease |
04/18/2013 | CA2850560A1 Compositions and methods for treating heart failure |
04/17/2013 | EP2581451A1 Compounds for inhibiting mammalian s-nitrosoglutathione reductase |
04/17/2013 | EP2581373A1 Benzo- or pyrido-imidazole derivative |
04/17/2013 | EP2581366A1 Renin Inhibitors |
04/17/2013 | EP2581092A1 Lipid metabolism-improving agent |
04/17/2013 | EP2581089A1 Manufacturing method for polyphenol composition |
04/17/2013 | EP2580317A1 Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof |
04/17/2013 | EP2579886A1 Phenolic compositions derived from apple skin and uses thereof |
04/17/2013 | EP2579882A1 Compositions and methods of treating no-option critical limb ischemia (cli) |
04/17/2013 | EP2579715A1 Applications of partially and fully sulfated hyaluronan |
04/17/2013 | CN1917899B Use of alkaline phosphatase for the detoxification of lps |
04/17/2013 | CN1854300B Recombinant plasmid containing PON gene and its use |
04/17/2013 | CN103052641A Novel fused heterocyclic derivatives useful as C-Met tyrosine kinase inhibitors |
04/17/2013 | CN103052633A Amids Substituted Indazole Derivativees As Ploy(adp-ribose)polymerase Inhibitors |
04/17/2013 | CN103052630A Highly crystalline valsartan |
04/17/2013 | CN103049662A Application method of response surface analysis to Chinese herbal compound studies |
04/17/2013 | CN103045601A Improved modulators of coagulation factors |
04/17/2013 | CN103045442A Geshen health wine and production method thereof |
04/17/2013 | CN103044555A Fused protein containing cFms extracellular fragments, preparation method and applications of fused protein with cFms extracellular fragments |
04/17/2013 | CN103044509A Gamma-cytidine-5'-disodium triphosphate crystal compound, and preparation method and drug composition of crystal compound |
04/17/2013 | CN103044477A Trimethyl silicon substituted benzopyran compound and application thereof |
04/17/2013 | CN103044460A 3,5,7-triphenyl-5H-thiazolo[3,2-a]pyrimidin derivatives and application thereof |
04/17/2013 | CN103044409A Puerarin derivative or pharmaceutically acceptable salt and application thereof |
04/17/2013 | CN103044404A Dabigatran derivatives, and preparation method and application thereof in antithrombosis |
04/17/2013 | CN103041375A Marine biological hemorrhoidal anti-inflammatory repairing lotion and preparation method thereof |
04/17/2013 | CN103041371A Application of adiponectin in preparing medicine for curing cerebral arterial thrombosis of old people |
04/17/2013 | CN103041361A Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof |
04/17/2013 | CN103041342A Healthcare shoe pad solution |
04/17/2013 | CN103041337A Formula of traditional Chinese medicine for treating Raynaud's disease |
04/17/2013 | CN103041336A Traditional Chinese medicine composition for treating coronary heart disease |
04/17/2013 | CN103041327A Traditional Chinese medicine for treating sick sinus syndrome single nucleotide and preparation method thereof |
04/17/2013 | CN103041319A Traditional Chinese medicine composition for assisting treatment of heart disease and relieving mental strain |
04/17/2013 | CN103041314A Traditional Chinese medicine composition for treating vasculitis and traumatic acute lymphangitis |
04/17/2013 | CN103041292A Traditional Chinese medicine for treating apoplexy |
04/17/2013 | CN103041289A Chinese medicinal hypertensive medicament |
04/17/2013 | CN103041285A Cerebral apoplexy commemorative sign treatment method by utilizing Chinese medicaments |
04/17/2013 | CN103041282A Traditional Chinese medicine for treating deficiency of spleen and kidney and preparation method of medicine |
04/17/2013 | CN103041270A Externally used traditional Chinese medicine capable of relieving angina |
04/17/2013 | CN103041264A Kudzuvine root brain-boosting and intelligence-boosting oral solution with function of preventing vascular dementia and preparation method thereof |
04/17/2013 | CN103041244A Traditional Chinese medicine formula for treating pulmonary heart disease |
04/17/2013 | CN103041239A Medicine composition |
04/17/2013 | CN103041205A Traditional Chinese medicine for curing sequelae of phlegm-heat and blood stasis type apoplexy |
04/17/2013 | CN103041200A Traditional Chinese medicine composition for treating cerebral hemorrhage |
04/17/2013 | CN103041198A Traditional Chinese medicine preparation for treating essential hypotension and preparation method of traditional Chinese medicine preparation |
04/17/2013 | CN103041197A Traditional Chinese medicine composition for treating hypertension |
04/17/2013 | CN103041196A Medicine for treating cerebral diseases |
04/17/2013 | CN103041195A Medicine for treating cardiac diseases |
04/17/2013 | CN103041191A Traditional Chinese medicine composition for reducing blood pressure |
04/17/2013 | CN103041190A Traditional Chinese medicine for treating yin-deficiency yang-hyperactivity type apoplexy |
04/17/2013 | CN103041188A Composition for improving symptoms of cerebrovascular disease |
04/17/2013 | CN103041177A Chinese medicament for treating diabetic foot |
04/17/2013 | CN103041175A Novel method for extracting alkaloid from spiranthes sinensis |
04/17/2013 | CN103041171A Medicine for treatment of menopause vertigo |
04/17/2013 | CN103041150A Formula of traditional Chinese medicine for treating essential hypotension |
04/17/2013 | CN103041136A Chinese medicine preparation for treating hypertension |
04/17/2013 | CN103041134A Traditional Chinese medicine composition for treating vital myocarditis |